![]() |
Lilly announces new data from two Phase II ramucirumab trials on NSCLC
Eli Lilly and Company today announced new data from two Phase II ramucirumab (IMC-1121B) trials in patients with non-small cell lung cancer (NSCLC).
More... |
| All times are GMT -7. The time now is 07:07 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021